
Featured
The Metabolic Mirage: Why GLP-1 Failures in Alzheimer's Trials Signal a Paradigm Shift in Neuro-Research
Recent 2026 clinical trials revealed that GLP-1 drugs like oral semaglutide failed to delay Alzheimer's progression, shattering the metabolic repurpos...
Read Full Story →